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 Abstract 
Objective 
This study aimed to assess the relationship between the cerebro-placental ratio (CPR) and 
intrapartum and perinatal outcomes in pregnancies complicated by pre-existing insulin 
dependent diabetes (pT1DM) mellitus, pre-existing non-insulin dependent diabetes mellitus 
(pT2DM) and gestational diabetes mellitus (GDM). 
 
Study Design 
This was a retrospective cohort study of 1281 women with diabetes mellitus birthing at the 
Mater Mothers’ Hospital in Brisbane between 2007 and 2015. The CPR in non-anomalous 
singleton fetuses was measured between 34+0 and 36+6 weeks gestation and compared 
between types of DM treatment groups and correlated with intrapartum and perinatal 
outcomes.  
 
Results  
Of the study cohort, 9.7% (124/1281) had pT1DM, 5.3% (68/1281) had pT2DM and 85.0% 
(1089/1281) had GDM. Of women with pT2DM and GDM, 61.8% (42/68) and 28.9% 
(315/1089) respectively, required insulin during pregnancy.  Women with pT1DM had an 
increased odds of having a CPR <5th centile (OR 3.73, 95%CI: 1.90-6.96, p=0.0001) or a CPR 
<10th centile (OR 3.01, 95%CI: 1.80-4.91, p<0.0001) respectively. The odds of a UA PI >90th 
centile (OR 2.69, 95% CI: 1.60-4.39, p=0.0001) was higher in the pT1DM cohort. There was 
however no significant difference in the mean MCA PI between the three groups. Stratification 
by CPR centiles (<10th centile vs. >10th centile) demonstrated a lower birth weight in the CPR 
<10th centile cohort for all DM categories.  The proportion of neonates with birth weights <10th 
centile were higher in the CPR <10th centile cohort with the GDM cohort having an odds ratio 
of 8.28 (95%CI 4.22-16.13, p<0.0001) of this complication. The CPR <10th centile cohort also 
had a greater proportion of adverse composite neonatal outcome regardless of type of DM.  
 
 Conclusions 
Regardless of the type of DM, a low CPR was associated with poorer neonatal outcomes. 
Women with pT1DM also had the highest mean UA PI and lowest mean CPR despite no 
difference in the mean MCA PI between the three groups. 
 
Key words: cerebro-placental ratio, pregnancy, diabetes mellitus, caesarean section, adverse 
perinatal outcome, fetal hypoxia 
 
 
 
Introduction 
Diabetes mellitus (DM) is a significant contributor to adverse obstetric and perinatal 
outcomes. Its prevalence is increasing with pre-existing DM affecting approximately 1% of 
Australian pregnancies and gestational diabetes mellitus (GDM) complicating a further 7% of 
all maternities. [1] There is now clear and unequivocal evidence that adverse pregnancy 
outcomes are strongly linked to maternal hyperglycaemia, both in the peri-conception period 
and throughout gestation. [2, 3] Although strict glycemic control does improve outcomes[4], 
there is still a higher rate of complications in women with DM and poorer perinatal outcomes, 
as well as exacerbation of existing maternal comorbidities, including hypertension, thyroid 
disease, pre-eclampsia and eclampsia. [2, 5]  
 
Given the increased risk of late pregnancy complications particularly stillbirth, some 
international guidelines [6] now recommend planned delivery (either caesarean birth or 
induction of labour) no later than 39+0 weeks gestation for pregnant women with type 1 or 
type 2 DM with no other complications and no later than 41+0 weeks for women with GDM. 
These guidelines also recommend assessment of fetal wellbeing late in pregnancy although 
the type of monitoring is often not specified.  
  
The cerebro-placental ratio (CPR) is the ratio of the Middle Cerebral Artery Pulsatility Index 
(MCA PI) to the Umbilical Artery Pulsatility Index (UA PI). It represents the severity of 
increased cerebral perfusion resulting from fetal hypoxia and is associated with a myriad of 
adverse perinatal outcomes. [7] Although there is relatively little research regarding the utility 
of the CPR in a diabetic cohort, recent data suggests that a low CPR (<10th centile) regardless 
of GDM treatment was associated with worse perinatal outcomes, increased rates of low birth 
weight and higher preterm birth rates. [8] The objective of this study thus was to assess the 
relationship between the CPR and outcomes in pregnancies complicated by pre-existing Type 
1 DM (pT1DM), pre-existing Type 2 DM (pT2DM) as well as women with GDM and to 
determine if the CPR measured at 34+0-36+6 weeks gestation is predictive of adverse 
obstetric and perinatal outcomes.  To our knowledge, there have been no studies assessing 
the value of the CPR in these specific cohorts.  
 
Methods 
This was a retrospective cross-sectional study of women with pregnancies complicated by DM 
birthing at the Mater Mothers’ Hospital in Brisbane, Australia between January 2007 and 
December 2015.  The Mater Mothers’ Hospital is a major tertiary centre and the largest 
maternity hospital in Australia with a birth rate of approximately 10,000 births per annum.  
Previous prospectively collected maternal demographic data was cross-referenced against the 
institution’s ultrasound and neonatal databases to correlate outcomes.  The study protocol 
was assessed and approved by the hospital’s Human Research Ethics Committee (Reference 
number HREC/14/MHS/37).  
 
All women with a non-anomalous singleton fetus and DM regardless if pre-existing or 
gestational, who underwent an ultrasound scan between 34+0–36+6 weeks gestation with 
 recorded data for both the MCA PI and UA PI (to enable calculation of the CPR) were eligible 
for inclusion in this study.  At the Mater Mothers’ Hospital all women with DM in pregnancy 
receive serial scans for growth and wellbeing with the final scan before delivery generally 
taking place between 34+0 and 36+6 weeks gestation.  
 
There were three DM cohorts: pT1DM, pT2DM and GDM. Demographic data collected 
included maternal age, parity, body mass index (BMI), ethnicity (Caucasian, Asian, Indigenous, 
Indian or other), smoking status, maternal disease (thyroid disease, hypertension) and mode 
of conception. Indigenous ethnicity refers to patients identifying as being of Aboriginal or 
Torres Strait Islander origin.  Gestational age was calculated using the last menstrual period 
or earliest ultrasound examination or by correlation with both.  Doppler parameters were 
recorded in the absence of fetal breathing movements. An automated tracing method 
incorporating at least three waveforms was employed and repeated three times to obtain the 
mean PI. The angle of insonation was maintained at <30. The MCA, either right or left, 
depending on waveform quality, was imaged using colour Doppler and its waveform recorded 
from the proximal third of the vessel distal to its origin at the circle of Willis. The UA Doppler 
waveforms were recorded from a free loop of cord. The CPR was calculated by dividing the 
MCA PI by the UA PI.  
 
Outcomes analysed included mode of, and indication for, delivery, birth weight, birth weight 
centile (<10th or >90th centile), preterm birth (<37 weeks gestation) and adverse perinatal 
outcome. Adverse perinatal outcome was defined as a composite measure of any of perinatal 
death (fetal or neonatal), Neonatal Critical Care Unit (NCCU) admission, severe respiratory 
distress, Apgar score <7 at 5 minutes, significant hypoglycaemia requiring treatment, acidosis 
at birth (pH ≤ 7.0 or lactate > 6 mmol/L). Outcomes were also stratified according to the CPR 
centiles (<10th vs. >10th centile).  
  
Given the retrospective nature of this study and the difficulty in applying a rigorous definition 
to the diagnosis of fetal compromise we adapted a pragmatic approach and used the primary 
indication for delivery/intervention as recorded in the perinatal database and cross-
referenced this with the operative notes. The diagnosis of fetal compromise would generally 
have been made on the basis of an abnormal fetal heart pattern, fetal scalp pH or lactate, fully 
accepting the limitations of this methodology in our analysis.  
 
Kruskal-Wallis tests were used for comparisons of medians where data showed a skewed 
distribution and ANOVA was used for comparisons of means between groups where the data 
was normally distributed.  Proportions were compared using Chi-square test or Fisher’s exact 
test where expected frequencies were <5.  Statistics are reported as mean (Standard 
Deviation (SD)) or median (Inter-quartile Range (IQR)) for normally and non-normally 
distributed variables respectively or as the number of observations with the percentage of 
total. Multivariate analysis was performed by logistic regression and odds ratio (OR) reported 
with 95% confidence intervals for the pT1DM group or the CPR <10th centile group vs. the 
other groups combined as appropriate. ORs were adjusted for birth weight and gestational 
age at delivery, with the exception of birth weight outcomes which were adjusted for 
gestational age only. Data were analyzed using R Commander (R Foundation for Statistical 
Computing, Vienna, Austria). Statistical significance was set at p<0.05. No adjustment was 
made for multiple comparisons. 
 
Results 
The final study population meeting all the inclusion criteria comprised 1281 women with 
diabetes mellitus. Of these, 9.7% (124/1281) had pT1DM, 5.3% (68/1281) had pT2DM and 
 85.0% (1089/1281) had GDM.  Of women with pT2DM and GDM, 61.8% (42/68) and 28.9% 
(315/1089) respectively, required insulin during pregnancy.   
 
Table 1 displays the maternal demographics for the diabetes cohort. The mean maternal age 
and median BMI were significantly different between the diabetes groups (p<0.0001), with 
the lowest age and BMI recorded in patients with pT1DM. Ethnicity also varied between the 
groups, with a higher proportion of Caucasian women in the pT1DM group compared to the 
pT2DM and GDM cohorts (87.9% vs 48.5% vs 38.7%, p<0.0001). Parity, the use of reproductive 
technologies, smoking, hypertension/PET and thyroid disease were also significantly different 
between groups. Higher proportions of smoking, hypertension and thyroid disease was 
observed in the pT1DM group.     
 
The mean CPR and mean UA PI were significantly different between diabetes groups 
(p<0.0001), with the lowest mean CPR and highest mean UA PI recorded in the pT1DM cohort. 
Furthermore, the proportion of fetuses with a CPR <5th and <10th centiles was significantly 
different between groups (11.3% vs. 2.9% vs. 3.5%, p=0.001 and 19.4% vs. 8.8% vs. 8.0%, 
p=0.0002 respectively). Women with pT1DM had an increased odds of having a CPR <5th 
centile (OR 3.73, 95%CI: 1.90-6.96, p=0.0001) or a CPR <10th centile (OR 3.01, 95%CI: 1.80-
4.91, p<0.0001) respectively. The odds of a UA PI >90th centile (OR 2.69, 95% CI: 1.60-4.39, 
p=0.0001) was also significantly higher in the pT1DM cohort. There was however no significant 
difference in the mean MCA PI between the three groups (p=0.081).  
 
Table 2 describes the perinatal outcomes for the groups. The mean gestational age at delivery 
was lowest in the pT1DM group. This was associated with an almost 6-fold increased rate of 
delivery before 37 weeks in the pT1DM group compared to the other groups (OR: 5.77, 95%CI: 
3.88-8.74, p<0.0001). Birthweight was also significantly different between groups with the 
 highest mean birthweight in the pT1DM cohort. There was no significant difference in the 
proportion of neonates with birth weights <10th centile, but a significantly higher proportion 
of babies were large for gestational age in the pT1DM group (OR 3.82, 95%CI: 2.34-6.15, 
p<0.0001) respectively. Significantly poorer perinatal outcomes were also observed in the 
pT1DM cohort with higher rates of NCCU admission, respiratory distress and hypoglycaemia 
compared to the other diabetes groups, corresponding to a 3-fold increased rate of composite 
adverse outcome (OR 3.39, 95%CI: 2.16-5.42, p<0.0001).   
 
Stratification by CPR centiles (<10th centile vs. >10th centile) demonstrated a lower birth 
weight in the CPR <10th centile cohort for all DM categories.  The proportion of women 
requiring an emergency caesarean section for non-reassuring fetal status was also increased 
in both the pT1DM and GDM cohorts. In addition, the proportion of neonates with birth 
weights <10th centile were also higher in the CPR <10th centile cohort with the GDM cohort, 
associated with an odds ratio of 8.28 (95%CI 4.22-16.13, p<0.0001) of this complication. The 
CPR <10th centile cohort also had a greater proportion of adverse composite neonatal 
outcome regardless of type of DM. The GDM cohort with CPR <10th centile was also at 
significantly increased risk of preterm birth (<37w) (OR 2.09, 95%CI 1.28-3.39, p=0.003).  
 
Comment 
The results of our study suggest that fetuses in women with pT1DM and pT2DM have lower 
mean CPR and higher mean UA PI compared to those with GDM, with the lowest mean CPR 
and highest mean UA PI seen in the pT1DM cohort. We did not find a significant difference in 
the MCA PI between the three DM cohorts, suggesting that the low CPR in the pT1DM group 
is likely to be mediated by increased resistance in placental perfusion reflected by the higher 
mean UA PI in this cohort. This finding is biologically plausible given that women with pre-
existing DM are more likely to have greater end organ microvascular disease including the 
 utero-placental circulation. There are numerous morphological abnormalities described in 
placental structure and development in women with pre-existing diabetes mellitus 
attributable to maternal hyperglycaemia and increased TNF production seen in these 
placentae which reduce trophoblast proliferation and endovascular invasion, thus directly 
impairing placental development and function. [3]  In addition, elevated levels of leptin, 
Insulin-like Growth Factors (IGF) and matrix metalloproteinases stimulate extensive 
production of extracellular matrix and result in basement membrane thickening, erythrocyte 
deformation and increased intra-placental blood viscosity. These result in increased capillary 
branching and surface area, dilatation and congestion of vessels, increased diffusion distance, 
edematous villous stroma, villous tree maturation defects and intra- and extra-villous fibrinoid 
and glycogen deposition. [3, 9-12]  These abnormalities are most evident in T1DM compared 
to T2DM and GDM placentae. [9, 11]  In addition, raised levels of glycosylated haemoglobin 
(a marker of glycaemic control) has been linked to increased UA resistance [13] with higher 
UA PI levels seen in T1DM patients compared to T2DM and GDM patients. [14]   
 
There is now good data, both from prospective[15, 16] and retrospective studies [17, 18] 
demonstrating that a low CPR is associated with suboptimal growth at term, increased rates 
of intrapartum compromise and emergency caesarean, poor condition at birth and increased 
rates of neonatal unit admission. In addition, a low CPR may also reflect a failure of a fetus to 
reach its genetic growth potential at term [19, 20] despite having a normal birth weight. 
Fetuses with reduced feto-placental reserves prior to labour have a decreased ability to 
tolerate the normal but progressive hypoxic stress caused by intrapartum uterine contractions 
which can reduce uterine blood flow by as much as 60%. [21] The CPR therefore reflects 
suboptimal placental function and associated fetal cardiovascular compensation and thus 
appears to be a better predictor of outcome than either the UA PI or MCA PI individually. [7]  
 Hence, it is likely to be a good modality for assessment of fetal wellbeing given the previously 
described specific placental abnormalities seen in diabetic pregnancies.   
 
Our results also indicate a correlation between mode of delivery and perinatal outcomes and 
a putative increase in diabetes severity (GDM – pT2DM – pT1DM), such that GDM women had 
the highest rates of SVD and pT1DM women had the highest rates of CS delivery, both elective 
and emergency.  Women with pT1DM had significantly higher rates of preterm birth, large for 
gestational age (LGA) babies, NCCU admission, respiratory distress and hypoglycaemia 
compared to the other groups. The proportion of CPR <10th centile was highest in the pT1DM 
cohort that had the highest rates of the composite adverse neonatal outcome. This finding 
was also noted in the other two DM cohorts as well, albeit at a lower proportion as that seen 
in the pT1DM group. 
 
The novel observation of our study is the positive correlation between CPR and diabetes 
severity. We report a significantly lower mean CPR in pT1DM women compared with the 
pT2DM and GDM cohorts. To our knowledge this finding has not previously been reported. 
Our results are in contradistinction to that of Bachanek et al. [22] and To & Mok [23] who 
found that there was no difference in the UA PI in pT1DM or GDM pregnancies respectively 
compared to controls. However, our findings are in agreement with Fadda et al.’s smaller 
study where it was shown that abnormal UA and MCA Doppler indices and a low CPR in GDM 
pregnancies were associated with adverse perinatal outcomes. [24]  Consistent with a recent 
study in women with pT1DM, showing that macrosomic fetuses had lower UA PIs[13], we too 
found that LGA fetuses (>90th centile) had higher mean CPRs compared to smaller fetuses. It 
is interesting that although the pT1DM cohort had the highest mean UA PI, this cohort also 
had the highest birth weights. Fetal growth is dependent on a number of factors including 
placental function and the availability of substrates as well as the influence of various 
 adipogenic and growth hormones. It is possible although speculative, that fetal metabolic and 
endocrine factors outweigh the limitations on growth posed by suboptimal placental function 
in some diabetic cohorts.   
 
The strengths of this study include the large number of cases stratified according to type and 
onset of DM from a single tertiary centre and the inclusion of clinically relevant outcomes.   
Limitations were primarily intrinsic to the retrospective nature of the study.  Spanning nine 
years, the study period was associated with evolution in hospital policy and practice with 
particular emphasis of the changing diagnostic criteria for GDM, potentially affecting the 
relationship between diabetes status, Dopplers and outcomes. In addition, inter- and intra-
sonographer variability was not known and not all outcomes of interest were reliably 
recorded. We were also unable to confirm adequacy of treatment and glycaemic control, the 
gestation at which the diagnosis of GDM had been made and the duration of treatment, all 
factors which could have confounded our findings. Despite these limitations we have shown 
that the changes in CPR in diabetic pregnancies regardless of type or onset appears to be 
mediated primarily by the umbilical artery resistance.  
 
Conclusions 
Our findings add to the increasing data on the utility of the CPR in risk stratification of late 
gestation pregnancies complicated by DM and may assist in clinical management.  Further 
prospective studies are required to establish the utility of the CPR in the management of these 
pregnancies.   
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 Table 1: Maternal demographics, intrapartum outcomes and ultrasound characteristics 
stratified by DM type  
 
Variable pT1DM 
(n=124) 
pT2DM 
 (n=68) 
GDM (n=1089) p-value  
Maternal age (years) § 29.1 [5.2] 33.6 [5.9] 32.5 [5.2] <0.0001 
BMI (kg/m2) ^  25.4 [22.4 – 
29.2] 
30.9 [27.6 – 
37.7] 
25.9 [22.1 – 
30.8] 
<0.0001 
Ethnicity *     
Caucasian 109 (87.9) 33 (48.5) 421 (38.7) <0.0001 
Asian 2 (1.6) 9 (13.2) 259 (23.8) <0.0001† 
Indigenous 2 (1.6) 5 (7.4) 6 (0.6) <0.001† 
Indian 0 (0) 4 (5.9) 148 (13.6) <0.0001† 
Other 8 (6.5) 13 (19.1) 236 (21.7) <0.001 
Parity*     
0 60 (48.4) 19 (27.9) 430 (39.5) 0.020 
1 64 (51.6) 49 (72.1) 659 (60.5) 0.020 
ART* 4 (3.2) 0 (0) 65 (6.0) 0.042† 
PET/Hypertension* 34 (27.4) 34 (35.3) 105 (9.7) <0.0001 
Thyroid disease* 20 (16.1) 2 (2.9) 95 (8.7) <0.01† 
Smoking* 34 (27.4) 15 (22.1) 126 (11.6) <0.0001 
Total length labour (mins)^  418.5 [250.5-
599] (n=50) 
227 [133-313] 
(n=38) 
276.0 [167-
443] (n=753) 
<0.001 
Mode of Delivery*     
SVD 22 (17.7) 25 (36.8) 524 (48.1) <0.0001 
Instrumental 10 (8.1) 8 (11.8) 138 (12.7) 0.33 
CS 92 (74.2) 35 (51.5) 427 (39.2) <0.0001 
Elective CS 52 (41.9) 16 (23.5) 221 (20.3) <0.0001 
Emergency CS 40 (32.3) 19 (27.9) 206 (18.9) <0.001 
NRFS 8 (6.5) 4 (5.9) 43 (3.9) 0.26† 
Other 32 (25.8) 15 (22.1) 163 (15.0) <0.01 
Gestation at US (weeks) §  35.4 [0.8] 35.588 [0.863] 35.633 [0.882] 0.021 
CPR § 1.86 [0.60] 1.94 [0.50] 2.08 [0.55] <0.0001 
UA PI § 0.94 [0.21] 0.87 [0.17] 0.85 [0.17] <0.0001 
MCA PI § 1.66 [0.38] 1.63 [0.35] 1.71 [0.34] 0.081 
CPR <5th centile* 14 (11.3) 2 (2.9) 38 (3.5) 0.001† 
CPR <10th centile* 24 (19.4) 6 (8.8) 87 (8.0) <0.001 
UA PI >90th centile* 23 (18.5) 7 (10.3) 82 (7.5) <0.001 
MCA PI  <5th centile* 8 (6.5) 5 (7.4) 44 (4.0) 0.19† 
 
§ Mean [SD] – data analysed by 1-way ANOVA 
^Median [25th centile – 75th centile] – data analysed by Kruskal-Wallis 
*Number (Percentage) – data analysed by Chi-squared test or Fisher’s exact test where 
indicated (†) 
 
BMI – Body Mass Index, ART – Assisted Reproductive Techniques, PET – Pre-eclampsia, CS – 
Caesarean Section, SVD – Spontaneous Vaginal Delivery, NRFS – Non-Reassuring Fetal Status, 
SD – standard deviation, IQR – Interquartile Range, CPR – Cerebroplacental Ratio, UA – 
Umbilical Artery, MCA – Middle Cerebral Artery, PI – Pulsatility Index 
 
 Table 2: Perinatal outcomes stratified by DM type 
 
Variable pT1DM 
(n=124) 
pT2DM 
(n=68) 
GDM 
(n=1089) 
p-value OR (95% CI) ‡ p-value 
Gestation at delivery 
(weeks) [SD] § 
36.7 [1.1] 37.3 [1.0] 38.0 [1.2] <0.0001 NA  
Delivery <37 weeks (n, 
%)* 
87 (70.2) 31 (45.6) 304 (27.9) <0.0001 5.77 (3.88-8.74) <0.0001 
BW (g) [SD] § 3515.1 
[610.8] 
3292.5 
[587.0] 
3227.8 
[535.7] 
<0.0001 NA  
BW <10th centile (n, %)* 4 (3.2) 3 (4.4) 55 (5.1) 0.72† 0.19 (0.051-0.52) 0.003 
LGA (BW≥90th centile) 
(n, %)* 
33 (26.6) 13 (19.1) 111 (10.2) <0.0001 3.82 (2.34-6.15) <0.0001 
Apgar score <7 at 5min (n, 
%)* 
3 (2.4) 2 (2.9) 21 (1.9) 0.63† 0.55 (0.12-1.84) 0.38 
Acidosis (pH≤<7.0 or 
Lactate>6) (n, %)* 
11 (8.9) 4 (5.9) 68 (6.2) 0.47† 1.81 (0.83-3.66) 0.11 
NCCU admission (n, %)* 66 (53.2) 14 (20.6) 186 (17.1) <0.0001 2.91 (1.85-4.57) <0.0001 
Respiratory distress (n, %)* 40 (32.3) 9 (13.2) 160 (14.7) <0.0001 1.43 (0.89-2.25) 0.13 
Hypoglycaemia (n, %)* 52 (43.0) 13 (19.4) 129 (11.9) <0.0001 2.59 (1.64-4.04) <0.0001 
Perinatal Death (n, %)* 0 (0) 0 (0) 5 (0.5) NA NA NA 
Composite adverse 
neonatal outcome (n, %)*  
91 (74.6) 27 (39.7) 349 (32.2) <0.0001 3.39 (2.16-5.42) <0.0001 
§ Mean (SD) – data analysed by 1-way ANOVA 
* Number (percentage) – data analysed by Chi-squared test or Fisher’s exact test where 
indicated (†) 
‡ Odds ratios are for the Insulin-treated group compared to other treatment groups 
 
BW – birth weight, LGA – large for gestational age, NCCU – neonatal intensive care unit, SD – 
standard deviation, OR – Odds Ratio, 95%CI – 95% Confidence Interval 
 
OR adjusted for birthweight and gestational age at delivery with exception of delivery <37 
weeks which is unadjusted and birth weight <10th centile and LGA which are adjusted for 
gestational age only. 
 
 
 
 
 
 
 
 
 
 Table 3: Intrapartum and perinatal outcomes stratified by DM type and CPR centile categories 
 
 
 pT1DM  (n=124) pT2DM  (n=68) GDM (n=1089) 
 CPR 
<10th 
centile 
(n=24) 
CPR  
10th 
centile 
(n=100) 
p-
value 
OR (95% 
CI) 
p-
value 
CPR 
<10th 
centile 
(n=6) 
CPR  
10th 
centile 
(n=62) 
p-value OR 
(95% CI)  
p-
value 
CPR 
<10th 
centile 
(n=87) 
CPR  
10th 
centile 
(n=996) 
p-value OR 
(95% 
CI) 
p-value 
Mean gestation at 
delivery (weeks) [SD]§ 
36.3 
[1.3] 
36.9 
[1.0] 
0.016   37.3 
[0.8] 
37.3 
[1.0] 
0.99   37.1 
[1.5] 
38.1 
[1.2] 
<0.0001   
Mean BW (g) [SD] § 3446.1 
[698.7] 
3531.7 
[590.5] 
0.54   3210.3 
[598.5] 
3300.5 
[590.25] 
0.72   2717.9 
[613.2] 
3272.1 
[505.0] 
<0.0001   
Mode of Delivery (n, 
%)* 
               
SVD 3 (12.5) 19 
(19.0) 
0.56† 0.58 
(0.12-
1.99) 
0.43 0 (0.0) 25 (40.3) 0.078† NA NA 44 
(50.6) 
480 
(47.9) 
0.63 1.21 
(0.75-
1.92) 
0.44 
Instrumental 1 (4.2) 9 (9.0) 0.69† 0.49 
(0.03-
2.94) 
0.51 1 (16.7) 7 (11.3) 0.54† 1.47 
(0.070-
11.54) 
0.74 12 
(13.8) 
126 
(12.6) 
0.74 1.22 
(0.60-
2.31) 
0.56 
CS 20 
(83.3) 
72 
(72.0) 
0.25 1.92 
(0.63-
7.26) 
0.28 5 (83.3) 30 (48.4) 0.20† 5.39 
(0.80-
10.71) 
0.14 31 
(35.6) 
396 
(39.5) 
0.48 0.74 
(0.45-
1.21) 
0.24 
Elective CS 11 
(45.8) 
41 
(41.0) 
0.67 1.22 
(0.48-
3.06) 
0.67 1 (16.7) 15 (24.2) 1† 0.62 
(0.031-
4.28) 
0.68 16 
(18.4) 
205 
(20.5) 
0.65 0.89 
(0.47-
1.58) 
0.69 
Emergency CS 9 (37.5) 31 
(31.0) 
0.54 1.30 
(0.48-
3.38) 
0.59 4 (66.7) 15 (24.2) 0.047† 6.67 
(1.15-
53.17) 
0.042 15 
(17.2) 
191 
(19.1) 
0.68 0.73 
(0.39-
1.31) 
0.31 
NRFS 3 (12.5) 5 (5.0) 0.18† 4.08 
(0.74-
20.19) 
0.085 0 (0.0) 4 (6.5) 1† NA NA 6 (6.9) 37 (3.7) 0.15† 1.15 
(0.39-
2.88) 
0.79 
 § Mean (SD) – data analysed by 1-way ANOVA 
* Number (percentage) – data analysed by Chi-squared test or Fisher’s exact test where indicated (†) 
 
CS – Caesarean Section, BW – birth weight, SD – standard deviation, OR – Odds Ratio, 95%CI – 95% Confidence Interval 
 
OR adjusted for birth weight and gestational age at delivery with exception of delivery <37 weeks which is unadjusted and birth weight <10th centile and LGA 
which are adjusted for gestational age only 
 
 
Other 6 (25.0) 26 
(26.0) 
0.92 0.79 
(0.25-
2.22) 
0.67 4 (66.7) 11 (17.7) 0.019 11.87 
(1.87-
104.86) 
0.012 9 (10.3) 154 
(15.4) 
0.21 0.58 
(0.26-
1.18) 
0.16 
BW <10th centile (n, 
%)* 
2 (8.3) 2 (2.0) 0.17† 2.21 
(0.21-
21.75) 
0.48 1 (16.7) 2 (3.2) 0.25† 6.25 
(0.26-
82.12) 
0.17 26 
(29.9) 
29 (2.9) <0.0001 8.28 
(4.22-
16.13) 
<0.0001 
Delivery <37 weeks (n, 
%)* 
18 
(75.0) 
69 
(69.0) 
0.56 1.35 
(0.51-
4.01) 
0.56 3 (50.0) 28 (45.2) 1† 1.21 
(0.21-
7.01) 
0.82 46 
(52.9) 
258 
(25.7) 
<0.0001 3.24 
(2.08-
5.06) 
<0.0001 
Composite neonatal 
outcome score (n, %)* 
21 
(87.5) 
70 
(70.0) 
0.11 2.19 
(0.59-
1.07) 
0.27 3 (50.0) 24 (38.7) 0.68† 1.78 
(0.27-
11.46) 
0.53 48 
(55.2) 
301 
(30.2) 
<0.0001 2.09 
(1.28-
3.39) 
0.003 
